Evidence map›Paper›PMID 33799290›Full record

ArticleEpidemics2021

Estimating the global reduction in transmission and rise in detection capacity of the novel coronavirus SARS-CoV-2 in early 2020.

Antoine Belloir, François Blanquart

Abstract read
In one paragraph

Article in Epidemics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Antoine BelloirEcole Polytechnique, Route de Saclay, 91120 Palaiseau, France.
François BlanquartCentre for Interdisciplinary Research in Biology (CIRB), Collège de France, CNRS, INSERM, PSL Research University, Paris, France; Infection Antimicrobials Modelling Evolution, UMR 1137, INSERM, Université de Paris, Paris, France. Electronic address: francois.blanquart@college-de-france.fr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To better control the SARS-CoV-2 pandemic, it is essential to quantify the impact of control measures and the fraction of infected individuals that are detected. To this end we developed a deterministic transmission model based on the renewal equation and fitted the model to daily case and death data in the first few months of 2020 in 79 countries and states, representing 4.2 billions individuals. Based on a region-specific infection fatality ratio, we inferred the time-varying probability of case detection and the time-varying decline in transmissiblity. As a validation, the predicted total number of infected was close to that found in serosurveys; more importantly, the inferred probability of detection strongly correlated with the number of daily tests per inhabitant, with 50 % detection achieved with 0.003 daily tests per inhabitants. Most of the decline in transmission was explained by the reductions in transmissibility (social distancing), which avoided 10 millions deaths in the regions studied over the first four months of 2020. In contrast, symptom-based testing and isolation of positive cases was not an efficient way to control the spread of the disease, as a large part of transmission happens before symptoms and only a small fraction of infected individuals was typically detected. The latter is explained by the limited number of tests available, and the fact that increasing test capacity often increases the probability of detection less than proportionally. Together these results suggest that little control can be achieved by symptom-based testing and isolation alone.

Indexed as

Communicable Disease ControlCOVID-19FemaleHumansMaleModels, TheoreticalPandemicsSARS-CoV-2Detection probabilityEpidemiologyMathematical modelSARS-CoV-2Test and isolate

Identifiers

PMID33799290
PMCPMC7894102

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.